Creatine | Malate | Malic Acid
Tricreatine malate is made up of three creatines bound to one malate. Both molecules are involved in supporting efficient cellular energy production. Creatine is named from the Greek word from meat (kreas), because it was originally discovered in skeletal muscle. It plays a key role in tissues, like muscles and the brain, that use high amounts of energy. Because it concentrates in muscles, the best food sources are red meat, pork, lamb, poultry, and fish. While we can make some creatine in the body, persons not eating meat might not make sufficient creatine to optimize tissue status. So creatine as a dietary supplement may be more important to take as a supplement for vegans and vegetarians. Creatine is used in the phosphocreatine (phosphagen) system. This system regenerates ATP from ADP in tissues, and is especially important in circumstances with high energy demand. Because of this role, creatine is often described as an ATP “buffer.” Malate is a salt of malic acid, a compound that was first identified in apple juice, leading to it being named for the Latin word for apple (mālum). Malate is an intermediate in the citric acid cycle, a circular pathway that helps turn food into energy (i.e., ATP) and build important biomolecules. Adding intermediates like malate into this cycle helps upregulate the flux (i.e., the cycle can essentially spin faster).
We opt to use creatine as tricreatine malate, instead of a creatine monohydrate or other form of creatine, when both creatine and malate play a role supporting pathways or processes in a formulation.
Tricreatine malate sourcing is focused on ensuring it is non-GMO, gluten-free and vegan.
Creatine is dose-dependent (see Neurohacker Dosing Principles) in the range it’s commonly dosed (up to about 5 grams a day). Dosage of creatine will vary depending on the purpose of a formulation. If the goal is to quickly saturate muscle stores for sports performance uses, higher doses (3-5 grams) are recommended. If the goal is to augment the diet, a lower dose taken consistently over time is recommended. It’s been estimated that an omnivore diet provides about 1 gram of creatine a day(1, 2) and that young adults make about 1 gram a day.(1, 3) This combination of what we get in the diet and make (i.e., biosynthesis) is needed to offset the approximately 2 grams of creatine we lose everyday. A low dose of creatine can contribute a significant degree to offsetting this daily loss.
Mitochondrial structure and function
Exercise performance (ergogenic effects)
Krebs cyle (citric acid cycle) function
1. J. T. Brosnan, R. P. da Silva, M. E. Brosnan, Amino Acids. 40, 1325–1331 (2011).
2. M. E. Brosnan, J. T. Brosnan, Amino Acids. 48, 1785–1791 (2016).
3. R. Cooper, F. Naclerio, J. Allgrove, A. Jimenez, J. Int. Soc. Sports Nutr. 9, 33 (2012).
4. E. Barbieri et al., Oxid. Med. Cell. Longev. 2016, 5152029 (2016).
5. L. M. Rambo et al., Amino Acids. 44, 857–868 (2013).
6. P. Klivenyi et al., Nat. Med. 5, 347–350 (1999).
7. L. Zhang et al., J. Agric. Food Chem. 65, 6991–6999 (2017).
8. C. R. R. Alves et al., Amino Acids. 43, 1803–1807 (2012).
9. J.-S. Ju, J. L. Smith, P. J. Oppelt, J. S. Fisher, Am. J. Physiol. Endocrinol. Metab. 288, E347–52 (2005).
10. R. B. Ceddia, G. Sweeney, J. Physiol. 555, 409–421 (2004).
11. B. Banerjee et al., Magn. Reson. Imaging. 28, 698–707 (2010).
12. B. Gualano et al., Med. Sci. Sports Exerc. 43, 770–778 (2011).
13. C. R. R. Alves et al., Arthritis Care Res. . 65, 1449–1459 (2013).
14. D. G. Burke et al., Med. Sci. Sports Exerc. 35, 1946–1955 (2003).
15. J. T. Brosnan, M. E. Brosnan, Annu. Rev. Nutr. 27, 241–261 (2007).
16. J. S. Volek et al., Med. Sci. Sports Exerc. 31, 1147–1156 (1999).
17. S. L. Nissen, R. L. Sharp, J. Appl. Physiol. 94, 651–659 (2003).
18. R. B. Kreider, Mol. Cell. Biochem. 244, 89–94 (2003).
19. L. A. Gotshalk et al., Eur. J. Appl. Physiol. 102, 223–231 (2008).
20. L. A. Gotshalk et al., Med. Sci. Sports Exerc. 34, 537–543 (2002).
21. J. D. Branch, Int. J. Sport Nutr. Exerc. Metab. 13, 198–226 (2003).
22. B. Op ’t Eijnde, B. Ursø, E. A. Richter, P. L. Greenhaff, P. Hespel, Diabetes. 50, 18–23 (2001).
23. V. Saks et al., J. Physiol. 571, 253–273 (2006).
24. C. A. Lygate et al., Cardiovasc. Res. 96, 466–475 (2012).
25. G. J. Brewer, T. W. Wallimann, J. Neurochem. 74, 1968–1978 (2000).
26. B. Valastro, A. Dekundy, W. Danysz, G. Quack, Behav. Brain Res. 197, 90–96 (2009).
27. R. T. Matthews et al., J. Neurosci. 18, 156–163 (1998).
28. P. G. Sullivan, J. D. Geiger, M. P. Mattson, S. W. Scheff, Ann. Neurol. 48, 723–729 (2000).
29. M. C. Rodriguez et al., Muscle Nerve. 35, 235–242 (2007).
30. M. Evans et al., Nutr. Metab. . 14, 7 (2017).
31. J. M. Berg, J. L. Tymoczko, G. J. Gatto, L. Stryer, Eds., Biochemistry (W.H. Freeman and Company, 8th ed., 2015).
32. C. B. Edwards, N. Copes, A. G. Brito, J. Canfield, P. C. Bradshaw, PLoS One. 8, e58345 (2013).
33. J.-L. Wu, Q.-P. Wu, Y.-P. Peng, J.-M. Zhang, Physiol. Res. 60, 329–336 (2011).
34. S. Ding, Y. Yang, J. Mei, Evid. Based. Complement. Alternat. Med. 2016, 3803657 (2016).
35. X. Zeng, J. Wu, Q. Wu, J. Zhang, Physiol. Res. 64, 71–78 (2015).
36. J.-L. Wu et al., Physiol. Res. 57, 261–268 (2008).
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.